Department of Nutritional Sciences, King's College London, London, United Kingdom.
Department of Nutrition and Dietetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Adv Nutr. 2021 Mar 31;12(2):503-522. doi: 10.1093/advances/nmaa108.
There is considerable heterogeneity across the findings of systematic reviews of oral nutritional supplement (ONS) interventions, presenting difficulties for healthcare decision-makers and patients alike. It is not known whether heterogeneity arises from differences in patient populations or relates to methodological rigor. This overview aimed to collate and compare findings from systematic reviews of ONSs compared with routine care in adult patients who were malnourished or at risk of malnutrition with any clinical condition and to examine their methodological quality. Three electronic databases were searched to July 2019, supplemented with hand-searching. Data on all outcomes were extracted and review methodological quality assessed using A MeaSurement Tool for Assessment of systematic Reviews (AMSTAR). Twenty-two reviews were included, 11 in groups from mixed clinical backgrounds and 11 in specific clinical conditions. Ninety-one meta-analyses were identified for 12 different outcomes but there was discordance between results. Significant benefits of ONSs were reported in 4 of 4 analyses of energy intake, 7 of 11 analyses of body weight, 7 of 22 analyses of mortality, 10 of 17 analyses of complications (total and infectious), 1 of 3 analyses of muscle strength, 4 of 9 analyses of body composition/nutritional status, 2 of 14 analyses of length of stay, and 2 of 5 analyses of hospital readmissions. Ten reviews were high quality (AMSTAR scores 8-11), 9 moderate (AMSTAR scores 3-8), and 3 poor (AMSTAR scores 0-3). Methodological deficiencies were limitations to searches, poor reporting of heterogeneity, and failure to incorporate quality of evidence into any recommendations. Discordance between reviews was not markedly reduced when only high-quality reviews were considered. Evidence for the effects of ONS in malnourished patients or those who are at risk of malnutrition is uncertain, and discordance in results can arise from differences in clinical background of patients or the etiological basis of malnutrition.
系统评价中口服营养补充(ONS)干预措施的结果存在很大的异质性,这给医疗保健决策者和患者都带来了困难。目前尚不清楚这种异质性是来自于患者人群的差异,还是与方法学的严谨性有关。本综述旨在汇总和比较成人营养不良或有营养不良风险的任何临床疾病患者接受 ONS 与常规护理的系统评价结果,并检查其方法学质量。检索了三个电子数据库,截止到 2019 年 7 月,补充了手工检索。提取了所有结局的数据,并使用评估系统评价的测量工具(AMSTAR)评估了综述的方法学质量。共纳入 22 项综述,其中 11 项来自混合临床背景的组,11 项来自特定临床条件。确定了 12 种不同结局的 91 项荟萃分析,但结果存在不一致。ONS 对 4 项能量摄入分析、11 项体重分析、22 项死亡率分析、17 项并发症(总并发症和感染性并发症)分析、3 项肌肉力量分析、9 项身体成分/营养状况分析、14 项住院时间分析和 5 项住院再入院分析有显著获益。10 项综述质量较高(AMSTAR 评分 8-11),9 项中等(AMSTAR 评分 3-8),3 项较差(AMSTAR 评分 0-3)。方法学缺陷限制了检索、异质性报告不良以及未能将证据质量纳入任何建议。当只考虑高质量综述时,综述之间的差异并没有明显减少。ONS 对营养不良患者或有营养不良风险患者的影响证据不确定,结果的不一致可能来自于患者临床背景的差异或营养不良的病因基础。